Finance
Exclusive-US Packaging Firm Silgan Signals Interest for Germany's Gerresheimer, Sources Say
Published by Global Banking & Finance Review®
Posted on March 20, 2026
2 min readLast updated: March 20, 2026
Quick Summary
Silgan Holdings has expressed interest in acquiring Germany’s Gerresheimer amid the latter’s deepening financial and regulatory troubles, including a BaFin investigation. Gerresheimer’s shares jumped following the news, though a deal remains uncertain and challenges persist.
Exclusive-US packaging firm Silgan signals interest for Germany's Gerresheimer, sources say
Silgan's Potential Acquisition of Gerresheimer: Key Developments
Silgan's Approach and Valuation
MUNICH, March 20 (Reuters) - U.S. packaging company Silgan Holdings has signalled interest in taking over German medical packaging maker Gerresheimer <GXIG.DE>, according to two sources familiar with the matter.
Silgan is working with advisers on the approach that could value Gerresheimer at 41 euros per share, one source said, cautioning that there is no certainty there will be a bid and that a transaction will be completed.
Responses from Involved Parties
Company Statements
Gerresheimer declined to comment.
Silgan was not immediately available for comment.
Market Reaction and Financial Overview
Share Price Movement
Gerresheimer shares rose 6.7% following the news to trade at 18.9 euros.
Company Valuation and Stock Performance
Gerresheimer, worth about 600 million euros ($694 million), has seen its shares drop more than 80% from its 2023 peak and the stock is down 37% since the start of the year.
Regulatory and Strategic Background
Financial Regulator Probe
The company said in late February that Germany's financial regulator BaFin is widening a probe into its financial statements, adding pressure on the medical products maker as it grapples with accounting issues and a plunging share price.
Previous Sale Talks
The Duesseldorf-based company held talks last year with private equity investors over a potential sale, but the conversations ended without an agreement.
Currency Exchange Rate
($1 = 0.8644 euros)
Reporting Credits
(Reporting by Alexander Huebner in Munich, Christoph Steitz in Frankfurt; Additional reporting by Milana Vinn in New York; writting by Andres Gonzalez; Editing by Miranda Murray and Louise Heavens)
Key Takeaways
- •Silgan’s inquiry into Gerresheimer comes as the German firm faces significant regulatory scrutiny and share‑price erosion from its 2023 peak (news.bloombergtax.com).
- •Silgan has a long history of acquisitive growth—completing around 40 deals and most recently buying Weener Plastics for €838 m in 2024 (silganholdings.com).
- •Gerresheimer’s share price surged 5.6 % on the takeover interest despite being down over 80 % from its 2023 high, pressured by BaFin’s expanded probe and accounting missteps (ad-hoc-news.de)
References
Frequently Asked Questions about Exclusive-US packaging firm Silgan signals interest for Germany's Gerresheimer, sources say
1Who is interested in acquiring Gerresheimer?
U.S. packaging company Silgan Holdings has signalled interest in taking over German medical packaging maker Gerresheimer.
2Is the Gerresheimer takeover by Silgan confirmed?
There is no certainty of a bid or of the transaction being completed, as Silgan is only working with advisers on the approach.
3Why has Gerresheimer's share price dropped?
Gerresheimer's share price has dropped over 80% from its 2023 peak, partly due to accounting issues and an ongoing probe by Germany's financial regulator BaFin.
4What is the value of Gerresheimer?
Gerresheimer is currently worth about 600 million euros ($694 million).
5Has Gerresheimer previously discussed a sale?
Yes, Gerresheimer held talks with private equity investors last year about a potential sale, but no agreement was reached.
